Eledon Pharmaceuticals
ELDN
ELDN
20 hedge funds and large institutions have $5.93M invested in Eledon Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
56% less capital invested
Capital invested by funds: $13.6M → $5.93M (-$7.65M)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$837K | |
| 2 | +$653K | |
| 3 | +$326K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$230K |
| 5 |
Renaissance Technologies
New York
|
+$210K |
Top Sellers
| 1 | -$44K | |
| 2 | -$2K | |
| 3 | -$714 | |
| 4 |
Morgan Stanley
New York
|
-$198 |